Avestria Ventures

Avestria Ventures is a San Francisco-based venture capital firm dedicated to investing in women's health and female-led life science and healthcare companies. Established with a clear mission to address the significant funding gap in these critical sectors, the firm focuses on innovative solutions across diagnostics, devices, digital health, therapeutics, and services that improve outcomes for women. Avestria seeks out companies with robust scientific foundations, a clear path to market, and the potential for substantial impact.

The firm typically engages with companies at the Seed, Series A, and early Series B stages of development. Avestria Ventures is known for its strategic approach, providing not just capital but also active support and leveraging its extensive network within the healthcare ecosystem to help portfolio companies scale. Their investment thesis is rooted in the belief that investing in women's health and female-led ventures represents both a significant market opportunity and a crucial step towards health equity.

Avestria Ventures has successfully raised two funds to date, demonstrating growing commitment and capacity. Their first fund closed at $25 million in 2019, followed by a second fund, Avestria Ventures II, LP, which closed at $50 million in February 2022. This brings their total assets under management to approximately $75 million. For initial investments, Avestria typically writes checks ranging from $500,000 to $3 million, with the capacity for follow-on investments as companies mature. This focused strategy positions Avestria as a key player in advancing innovation within the women's health and diverse leadership spaces.